Back to filter
Original filing (PDF)20251008150623NAL0003378547001
ON DEMAND PHARMACEUTICALS
Form 5500
FILING_RECEIVED
ON DEMAND PHARMACEUTICALS 401(K) PLAN
401(k) retirement plan
Active participants
23
Accounts w/ balance
109
Plan assets (EOY)
$4.6M
Net assets (EOY)
$4.6M
Plan health score (directional)
90
/ 100
Grade A
Top-tier plan health
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
100
Concentration risk
75
Total plan cost
80
Vendor stack
100
Participation health
100
Knocking points off
- 64 bps in Schedule C fees — modestly above peer band of 52 bps.
Helping the score
- Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for ON DEMAND PHARMACEUTICALS.
Plan sponsor
Name
ON DEMAND PHARMACEUTICALS
EIN
37-1802433
Address
1550 EAST GUDE DR · ROCKVILLE, MD · 20850
Phone
(301) 701-6814
Industry
Manufacturingsee all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-10-08
Pension benefit codes
2A · Age/service weighted or new comparability
2E · Profit-sharing
2F · ERISA section 404(c)
2G · Total participant-directed accounts
2J · 401(k) feature
2T · Default investment account (QDIA)
3D · Pre-approved plan (master / prototype / VS)
Audit & trust (Schedule H)
Auditor
BELFINT, LYONS & SHUMAN, P.A.
Trustee / custodian
—
Trustee phone
—
Service providers (Schedule C)
1 rowsRecordkeeper
1| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| T. ROWE PRICE | 04-3257927 | KANSAS CITY, MO | RECORDKEEPER | $29K | — |
Investments
The Schedule of Assets is filed as a free-form PDF attachment on EFAST2; we parse these offline and coverage is partial (priority is the largest plans by EOY assets). This plan also reports no pooled (Schedule D) interests, so its holdings aren’t hidden on a master-trust filing. The line-item data lives on DOL EFAST2 under the same ACK_ID.
See Methodology > Data linkages for how Form 5500 / Schedule H / Schedule D / Schedule of Assets fit together.
Related plans
Other plans using T. ROWE PRICE
RTX CORPORATION
RTX SAVINGS PLAN MASTER TRUST
$58.3B
CVS HEALTH CORPORATION
CVS HEALTH FUTURE FUND 401(K) PLAN
$30.1B · 313,966 participants
HCA INC.
HCA INC. MASTER RETIREMENT TRUST
$23.4B
TRUSTEES OF THE NATIONAL ELECTRICAL ANNUITY PLAN
NATIONAL ELECTRICAL ANNUITY PLAN
$18.1B · 89,789 participants
PACIFIC GAS AND ELECTRIC COMPANY
PACIFIC GAS AND ELECTRIC COMPANY RETIREMENT PLAN
$17.6B · 28,573 participants
SANOFI-AVENTIS US LLC
SANOFI U.S. GROUP SAVINGS PLAN
$8.5B · 13,179 participants
Similar-size Manufacturing plans
VORTECH PHARMACEUTICALS, LTD.
VORTECH PHARMACEUTICALS, LTD. PROFIT SHARING PLAN
$4.5M · 6 participants
DENISON PHARMACEUTICALS, LLC
DENISON PHARMACEUTICALS, INC. 401(K) PROFIT SHARING PLAN
$4.5M · 112 participants
FAR RESEARCH, INC.
FAR RESEARCH, INC. DBA FAR CHEMICAL 401K PROFIT SHARING PLAN
$4.5M · 38 participants
SIGHTGLASS MGMT, INC.
KIVA BRANDS RETIREMENT PLAN
$4.5M · 364 participants
PURE PRESCRIPTIONS, INC.
PURE PRESCRIPTIONS, INC. 401(K) PROFIT SHARING PLAN
$4.6M · 6 participants
VERO BIOTECH INC
VERO BIOTECH INC. 401(K) PLAN
$4.6M · 219 participants
Large plans in Maryland
LOCKHEED MARTIN CORPORATION
LMC DEFINED CONTRIBUTION MASTER TRUST
$56.1B
LOCKHEED MARTIN CORPORATION
LOCKHEED MARTIN CORPORATION SALARIED SAVINGS PLAN
$51.4B · 94,445 participants
T. ROWE PRICE TRUST COMPANY
T. ROWE PRICE INSTITUTIONAL COMMON TRUST FUND, T. ROWE PRICE GROWTH STOCK TRUST
$36.0B
T. ROWE PRICE TRUST COMPANY
T.ROWE PRICE STRATEGIC COMMON TRUST FUND, T.ROWE PRICE RETIREMENT 2040 TRUST
$35.2B
T. ROWE PRICE TRUST COMPANY
T.ROWE PRICE STRATEGIC COMMON TRUST FUND, T.ROWE PRICE RETIREMENT 2030 TRUST
$35.0B
T. ROWE PRICE TRUST COMPANY
T.ROWE PRICE STRATEGIC COMMON TRUST FUND, T.ROWE PRICE U.S. VALUE EQUITY TRUST
$32.2B